Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03298802 · ClinicalTrials.gov registry record · Phase 3
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
A Phase 3 study, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- Phase 3
- Development phase
- 453
- Enrollment target
NCT03298802: Clinical Trial Phase 3 study, sponsored by The University of Texas Medical Branch, Galveston.
NCT03298802 is a Phase 3 study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 453 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (41% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03298802, a Phase 3 study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 453 participants
- Enrollment target
Study Summary
Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension.
Primary Outcome
Any participants who had a visit to the hospital during the 1-6 weeks postpartum.
Interventions
- DRUG Placebo Tablet
- DRUG Hydrochlorothiazide 50mg Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 453 participants |
| Start Date | 2017-11-21 |
| Est. Completion | 2025-04-22 |
| Phase | Phase 3 |
Why NCT03298802 stopped before completion
NCT03298802 is an interventional study that assigns participants to a tested intervention. The registered 453 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (41% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo Tablet is the first listed.
NCT03298802 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03298802 about?
NCT03298802 is a clinical study titled "Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide". Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension.
What is the current status of trial NCT03298802?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 453 participants. The study started on 2017-11-21. Estimated completion is 2025-04-22.
What interventions are being tested in trial NCT03298802?
The interventions under investigation include: Placebo Tablet (DRUG), Hydrochlorothiazide 50mg Tablet (DRUG).
Who is sponsoring clinical trial NCT03298802?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03298802's enrollment target sits among peer trials
453 834th of 2000 higher than 1,166 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03460977 · 453 participants · Phase 1
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NCT04708171 · 453 participants
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
- NCT05489211 · 454 participants · Phase 2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- NCT05655936 · 454 participants · NA
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI